Chemoinformaics analysis of Naringin-7-O-Alpha-L-Rhamno-Glucoside
Molecular Weight | 580.539 | nRot | 6 |
Heavy Atom Molecular Weight | 548.283 | nRig | 30 |
Exact Molecular Weight | 580.179 | nRing | 5 |
Solubility: LogS | -3.43 | nHRing | 3 |
Solubility: LogP | -0.493 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 14 | No. of Arom Bond | 12 |
nHA | 14 | APOL | 77.6554 |
nHD | 8 | BPOL | 41.6506 |
QED | 0.202 |
Synth | 4.738 |
Natural Product Likeliness | 2.246 |
NR-PPAR-gamma | 0.94 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.974 |
HIA | 0.927 |
CACO-2 | -6.501 |
MDCK | 0.0000937 |
BBB | 0.347 |
PPB | 0.787384 |
VDSS | 0.372 |
FU | 0.219088 |
CYP1A2-inh | 0.004 |
CYP1A2-sub | 0.025 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.124 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.682 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.196 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.058 |
CL | 1.489 |
T12 | 0.202 |
hERG | 0.015 |
Ames | 0.348 |
ROA | 0.245 |
SkinSen | 0.031 |
Carcinogencity | 0.795 |
EI | 0.007 |
Respiratory | 0.033 |
NR-Aromatase | 0.516 |
Antiviral | Yes |
Prediction | 0.863477 |